The company has significantly improved its development of an new treatment for amyloid heart disease, employing the compound. Preliminary clinical data indicates significant improvements for patients affected with the https://biotech863263.losblogos.com/40799144/company-advances-cardiac-amyloidosis-therapy-through-the-therapy